These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7084814)

  • 1. Preparation of a stable phospholipid reagent for coagulation assays.
    Barrowcliffe TW; Stocks J; Gray E
    Haemostasis; 1982; 11(2):96-101. PubMed ID: 7084814
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation of a sensitive partial thromboplastin reagent from bovine brain.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):287-94. PubMed ID: 1643206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new Russian phospholipid reagent from soybeans for the study of activated partial thromboplastin time].
    Staritsyna NN; Shanskaia AI; Khrolova PV; Papaian LP
    Klin Lab Diagn; 1993; (6):43-5. PubMed ID: 8032782
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of soybean reagent for determination of activated partial thromboplastin time].
    Shanskaia AI; Staritsyna NN; Khrolova PV; Papaian LP
    Gematol Transfuziol; 1995; 40(5):41-3. PubMed ID: 8566661
    [No Abstract]   [Full Text] [Related]  

  • 8. Methodical aspects of blood coagulation measurements in birds applying commercial reagents--a pilot study.
    Guddorf V; Kummerfeld N; Mischke R
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):322-7. PubMed ID: 25080826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of phospholipids associated with fibrins in partial thromboplastin test.
    Ogawa S; Kurokawa I; Akino T
    Tohoku J Exp Med; 1983 Sep; 141(1):61-9. PubMed ID: 6636150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of reagents used for the determination of activated partial thromboplastin time to defects in the intrinsic mechanism of coagulation].
    Ciavarella N; Coccheri S; Mannucci PM; Mariani G; Mori PG; Orlando M; Ponari O; Tentori L
    Ric Clin Lab; 1981; 11 Suppl 2():41-53. PubMed ID: 7323616
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for testing APC resistance in thrombophilic patients.
    Sochynsky CL; Joyner A; Ortel TI
    Am Clin Lab; 1994 Jul; 13(7):26-7. PubMed ID: 10147384
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of a partial thromboplastin reagent containing a non-settling, particulate activator.
    Babson AL; Babson SR
    Am J Clin Pathol; 1974 Dec; 62(6):856-60. PubMed ID: 4372878
    [No Abstract]   [Full Text] [Related]  

  • 15. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N
    J Thromb Haemost; 2012 Nov; 10(11):2338-43. PubMed ID: 22909048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
    Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
    Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrophosphatide: a reagent for coagulation studies].
    Rakitianskaia AA; Khomich EN; Gilevskiĭ EN
    Lab Delo; 1982; (1):32-4. PubMed ID: 6174785
    [No Abstract]   [Full Text] [Related]  

  • 18. [Simple search test in pre- and postoperative blood coagulation disorders].
    Encke A
    Z Prakt Anasth; 1970 Feb; 5(1):66-8. PubMed ID: 4256219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation tests ].
    Fukue H; Fukutake K
    Rinsho Byori; 1997 Nov; Suppl():99-106. PubMed ID: 9508613
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
    Tripodi A; Arbini A; Chantarangkul V; Mannucci PM
    Thromb Haemost; 1992 Jan; 67(1):42-5. PubMed ID: 1615481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.